Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression.

Yang YJ, Han JW, Youn HD, Cho EJ.

Nucleic Acids Res. 2010 Jan;38(2):382-90. doi: 10.1093/nar/gkp991. Epub 2009 Nov 11.

2.

The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+)mice.

Kawasaki Y, Tsuji S, Muroya K, Furukawa S, Shibata Y, Okuno M, Ohwada S, Akiyama T.

EMBO Rep. 2009 Dec;10(12):1355-62. doi: 10.1038/embor.2009.233. Epub 2009 Nov 6.

3.

Tumour suppression by p53: a role for the DNA damage response?

Meek DW.

Nat Rev Cancer. 2009 Oct;9(10):714-23. doi: 10.1038/nrc2716. Epub 2009 Sep 4. Review.

PMID:
19730431
4.

RVB1/RVB2: running rings around molecular biology.

Jha S, Dutta A.

Mol Cell. 2009 Jun 12;34(5):521-33. doi: 10.1016/j.molcel.2009.05.016. Review.

5.

A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity.

Ding L, Paszkowski-Rogacz M, Nitzsche A, Slabicki MM, Heninger AK, de Vries I, Kittler R, Junqueira M, Shevchenko A, Schulz H, Hubner N, Doss MX, Sachinidis A, Hescheler J, Iacone R, Anastassiadis K, Stewart AF, Pisabarro MT, Caldarelli A, Poser I, Theis M, Buchholz F.

Cell Stem Cell. 2009 May 8;4(5):403-15. doi: 10.1016/j.stem.2009.03.009. Epub 2009 Apr 2.

6.

The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression.

Shema E, Tirosh I, Aylon Y, Huang J, Ye C, Moskovits N, Raver-Shapira N, Minsky N, Pirngruber J, Tarcic G, Hublarova P, Moyal L, Gana-Weisz M, Shiloh Y, Yarden Y, Johnsen SA, Vojtesek B, Berger SL, Oren M.

Genes Dev. 2008 Oct 1;22(19):2664-76. doi: 10.1101/gad.1703008.

7.

Pontin and reptin, two related ATPases with multiple roles in cancer.

Huber O, Ménard L, Haurie V, Nicou A, Taras D, Rosenbaum J.

Cancer Res. 2008 Sep 1;68(17):6873-6. doi: 10.1158/0008-5472.CAN-08-0547. Review.

8.

IRF4 addiction in multiple myeloma.

Shaffer AL, Emre NC, Lamy L, Ngo VN, Wright G, Xiao W, Powell J, Dave S, Yu X, Zhao H, Zeng Y, Chen B, Epstein J, Staudt LM.

Nature. 2008 Jul 10;454(7201):226-31. doi: 10.1038/nature07064. Epub 2008 Jun 22.

9.

Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?

Felsher DW.

Cancer Res. 2008 May 1;68(9):3081-6; discussion 3086. doi: 10.1158/0008-5472.CAN-07-5832. Review.

10.

Oncogene addiction.

Weinstein IB, Joe A.

Cancer Res. 2008 May 1;68(9):3077-80; discussion 3080. doi: 10.1158/0008-5472.CAN-07-3293. Review.

11.

Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells.

Minsky N, Shema E, Field Y, Schuster M, Segal E, Oren M.

Nat Cell Biol. 2008 Apr;10(4):483-8. doi: 10.1038/ncb1712. Epub 2008 Mar 16.

PMID:
18344985
12.

Control of transcription by Pontin and Reptin.

Gallant P.

Trends Cell Biol. 2007 Apr;17(4):187-92. Epub 2007 Feb 22. Review.

PMID:
17320397
13.

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW.

Nature. 2007 Feb 8;445(7128):656-60. Epub 2007 Jan 24. Erratum in: Nature. 2011 May 26;473(7348):544.

14.

Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II.

Pavri R, Zhu B, Li G, Trojer P, Mandal S, Shilatifard A, Reinberg D.

Cell. 2006 May 19;125(4):703-17.

15.

ETS transcription factors and their emerging roles in human cancer.

Seth A, Watson DK.

Eur J Cancer. 2005 Nov;41(16):2462-78. Epub 2005 Oct 6. Review.

PMID:
16213704
16.

The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.

Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D, Krek W.

Mol Cell Biol. 2005 Jun;25(12):5052-60.

17.

Gefitinib--a novel targeted approach to treating cancer.

Herbst RS, Fukuoka M, Baselga J.

Nat Rev Cancer. 2004 Dec;4(12):956-65. doi: 10.1038/nrc1506. Review.

PMID:
15573117
18.

Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.

Fisher GH, Wellen SL, Klimstra D, Lenczowski JM, Tichelaar JW, Lizak MJ, Whitsett JA, Koretsky A, Varmus HE.

Genes Dev. 2001 Dec 15;15(24):3249-62.

19.

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, Jacks T, Tuveson DA.

Genes Dev. 2001 Dec 15;15(24):3243-8.

20.

The ETS-domain transcription factor family.

Sharrocks AD.

Nat Rev Mol Cell Biol. 2001 Nov;2(11):827-37. Review.

PMID:
11715049

Supplemental Content

Support Center